Haley A. Chatelaine

Haley A. Chatelaine

Auto-generated profile, based on publicly available information

Haley A. Chatelaine

National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 October 2023 in Nature Metabolism
Verified
Journal Article
Closed access
PDF file
HFHarriett Fuller
Harriett Fuller
YZYiwen Zhu
Yiwen Zhu
JNJayna Nicholas
Jayna Nicholas
HCHaley A. Chatelaine
Haley A. Chatelaine
EDEmily M. Drzymalla
Emily M. Drzymalla
BDBurcu F. Darst
Burcu F. Darst

7 December 2020 in Molecular Nutrition & Food Research
Verified
Journal Article
Closed access
PDF file
HCHaley Chatelaine
Haley Chatelaine
PDPriyankar Dey
Priyankar Dey
XMXiaokui Mo
Xiaokui Mo
EMEunice Mah
Eunice Mah
Richard BrunoRichard Bruno
Richard Bruno
RKRachel Kopec
Rachel Kopec

6 August 2026 in Current Opinion in Biotechnology
Verified
Journal Article
Closed access
Ewy MathéEwy Mathé
Ewy Mathé
Justin Van der HooftJustin Van der Hooft
Justin Van der Hooft
HCHaley Chatelaine
Haley Chatelaine
LNLouis-Félix Nothias
Louis-Félix Nothias
SRStacey Reinke
Stacey Reinke
Soha HassounSoha Hassoun
Soha Hassoun

9 October 2026 in Analytical Chemistry
Verified
Journal Article
Open access
HCHaley Chatelaine
Haley Chatelaine
CBCristina Balcells
Cristina Balcells
Stephen BarnesStephen Barnes
Stephen Barnes
DBDjawed Bennouna
Djawed Bennouna
JCJustin Cross
Justin Cross
Ewy MathéEwy Mathé
Ewy Mathé
The clinical utility of metabolomics hinges on reproducibly detecting differences between groups across analytical platforms. A first step toward assuring clinical reliability is establishing the ability to correctly classify heterogeneous mixtures across multiple platforms. No multi-lab studies to date have attempted to use metabolomic profiles to reproducibly cluster heterogeneous mixtures. We evaluated the reproducibility of the TruQuant metabolomics approach in eight labs in the US and UK. Each lab received identical aliquots of 32 samples, containing known mixtures of beef (A), chicken (B), and/or pork (C) extracts of varying homogeneity levels. Metabolomic profiles were generated for each mixture in duplicate using each lab’s LC−MS methods. Anonymized, processed data were analyzed centrally. Despite differences in the number of features detected (560−1727 features), all labs correctly differentiated sample mixture types via unsupervised approaches, with generally strong clustering across labs (NMF-adjusted rand index (ARI) = 1 for all labs except one (ARI = 0.84), unsupervised random forest silhouette score mean = 0.58 ± 0.14). Pearson correlations of suppression-corrected metabolite abundances, compared between lab pairs, were also strong for metabolites that were matched using authentic standards (mean = 0.87 ± 0.12 across all labs). Notably, we evaluated the suitability and impact of different data transformation approaches to make lab-to-lab comparisons. Overall, this “round-robin” study design and data show that metabolomic analyses, with appropriate study designs and data handling, enable reproducible conclusions across labs and platforms.

21 October 2022 in Molecular Nutrition & Food Research
Verified
Journal Article
Open access
HCHaley A. Chatelaine
Haley A. Chatelaine
CRCynthia A. Ramazani
Cynthia A. Ramazani
KSKyle Spencer
Kyle Spencer
SOSusan Olivo‐Marston
Susan Olivo‐Marston
MBMichael T. Bailey
Michael T. Bailey
RKRachel Kopec
Rachel Kopec
Scope: Colon metabolomes associated with high‐fat (H) versus energy‐restricted (E) diets in early colorectal cancer (CRC) models have never been directly compared. The objectives of this study are to elucidate metabolites associated with diet, aberrant crypt foci (ACF), and diet:ACF interaction, using a lifetime murine model.Methods and results: Three‐week‐old mice consumed control (C), E, or H initiation diets for 18 weeks. ACF formation is initiated weeks 16–21 with azoxymethane injections, followed by progression diet crossover (to C, E, or H) through week 60. Colon extracts are analyzed using ultra‐high‐performance liquid chromatography‐high resolution mass spectrometry (UHPLC‐HRMS). Metabolites associated with diet, ACF, or diet:ACF are determined using regression models (FDR‐adjusted p‐value <0.05). No metabolites are significantly associated with initiation diets, but concentrations of acylcarnitines and phospholipids are associated with C, E, and H progression diets. Purines, taurine, and phospholipids are associated with ACF presence. No significant associations between metabolites and diet:ACF interaction are observed.Conclusions: These results suggest that recent, rather than early‐life, diet is more closely associated with the colon metabolome, particularly lipid metabolism. Results from this study also provide candidate biomarkers of early CRC development and provide support for the importance of early diet on influencing pre‐CRC risk.

8 January 2024 in Nature Metabolism
Verified
Journal Article
Open access
PDF file
HFHarriett Fuller
Harriett Fuller
YZYiwen Zhu
Yiwen Zhu
JNJayna Nicholas
Jayna Nicholas
HCHaley A. Chatelaine
Haley A. Chatelaine
EDEmily M. Drzymalla
Emily M. Drzymalla
BDBurcu F. Darst
Burcu F. Darst